Warfarin Metabolites in Patients Following Cardiac Valve Implantation: A Contribution of Clinical and Genetic Factors

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Warfarin Metabolites in Patients Following Cardiac Valve Implantation: A Contribution of Clinical and Genetic Factors

Abstract: We conclude that not only genetic, but also several clinical factors affect warfarin metabolites in patients following cardiac valve implantation.

Cited by 3 publications

References 29 publications

Evolutionary synthetic oversampling technique and cocktail ensemble model for warfarin dose prediction with imbalanced data

Evolutionary synthetic oversampling technique and cocktail ensemble model for warfarin dose prediction with imbalanced data

An Ensemble Model With Clustering Assumption for Warfarin Dose Prediction in Chinese Patients

A Post-Hoc Interpretable Ensemble Model to Feature Effect Analysis in Warfarin Dose Prediction for Chinese Patients

Contact Info

Product

Resources

About